Trials / Unknown
UnknownNCT05463614
Population Pharmacokinetics of Propafenone and Propranolol in Children Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
The use of propafenone and propranolol in children during clinical treatment was depending mostly on experience. Besides, there was no recommended dose for children in drug instruction. Therefore, the investigators' aim is to study the pharmacokinetics and pharmacodynamics in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propafenone and Propranolol | Propafenone Hydrochloride Tablets, 100-200mg, 1 or 2 times per day; Propranolol Hydrochloride Sustained-Release Capsules, 40mg, 1 times per day |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2022-08-01
- Completion
- 2025-12-01
- First posted
- 2022-07-19
- Last updated
- 2022-07-19
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05463614. Inclusion in this directory is not an endorsement.